Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma - Preliminary results

---

Autoria(s): Obermair, A.; Cheuk, R.; Horwood, K.; Janda, M.; Bachtiary, B.; Schwanzelberger, B.; Stoiber, A.; Nicklin, J. L.; Perrin, L. C.; Crandon, A. J.

Contribuinte(s)	Robert V. P. Hutter
Data(s)	01/08/2001
Identificador	http://espace.library.uq.edu.au/view/UQ:60947
Idioma(s)	eng
Publicador	John Wiley & Sons, Inc., Journals
Palavras-Chave	#Oncology #Cervical Carcinoma #Hemoglobin Level #Chemoradiation #Prognostic Factor #Gynecologic-oncology-group #Phase-i-ii #Radiation-therapy #Prognostic Value #Pelvic Radiation #Cancer #Radiotherapy #Chemotherapy #Anemia #Cisplatin #C1 #321014 Obstetrics and Gynaecology #730108 Cancer and related disorders
Tipo	Journal Article